Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents

Journal of Steroid Biochemistry and Molecular Biology

Volumn 79, Issue 1-5, 2001, Pages 75-84

  Brueggemeier, Robert W ^a   Richards, Jeanette A ^a   Joomprabutra, Surachai ^a   Bhat, Abhijit S ^a   Whetstone, Jennifer L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aromatase; Benzopyranone; Combinatorial chemistry; Cyclooxygenase 1 and 2; Flavonoids; Prostaglandin E2

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; 17 PHENYLTRINOR; ALKYNE DERIVATIVE; ANDROGEN; AROMATASE; BENZOPYRANONE; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME; CYTOCHROME P19; CYTOCHROME P450; DEXAMETHASONE; ENZYME ACTIVATOR; ENZYME INHIBITOR; ESTROGEN; FLAVONE DERIVATIVE; PROSTAGLANDIN E2; RECEPTOR SUBTYPE; SALICYLIC ACID DERIVATIVE; SULPROSTONE; UNCLASSIFIED DRUG;

BINDING AFFINITY; BREAST; BREAST CANCER; BREAST TUMOR; CANCER GROWTH; CANCER LOCALIZATION; COMBINATORIAL CHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DETERMINATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; ESTROGEN SYNTHESIS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; STROMA CELL; STRUCTURE ANALYSIS;

AROMATASE; AROMATASE INHIBITORS; BENZOPYRANS; BREAST; BREAST NEOPLASMS; CELLS, CULTURED; COMBINATORIAL CHEMISTRY TECHNIQUES; DINOPROSTONE; DRUG DESIGN; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; HUMANS; RECEPTORS, PROSTAGLANDIN; STROMAL CELLS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0035717459     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00127-3     Document Type: Conference Paper

References (60)

1. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
2. Tissue-specific promoters regulate aromatase cytochrome P450 expression
3. Purification and characterization of human placental aromatase cytochrome P450
4. Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies
5. Regulation of aromatase activity within the breast
6. Interleukin-1 and interleukin-6 in breast cyst fluid: Their role in regulating aromatase activity in breast cancer cells
7. The role of aromatase in breast tumors
8. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcriptase
9. 2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene
10. Aromatase gene expression and its exon I usage in human breast tumors
11. Regulation of arachidonic acid metabolism, aromatase activity, and growth in human breast cancer cells by interleukin-1β and phorbol ester
12. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2
13. Prostaglandin endoperoxide synthase: Why two isoforms?
14. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
15. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
16. Prostaglandin synthase 2
17. Cyclooxygenase 2 induction: Molecular mechanism and pathophysiologic roles
18. Prostaglandins and breast cancer
19. The production of prostanoids in human cancers and their implications for tumor progression
20. Cyclooxygenase-2 gene expression in human breast cancer
21. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
22. Phytoestrogens: Epidemiology and a possible role in cancer protection
23. Soybean phytoestrogen intake and cancer risk
24. Soybeans inhibit mammary tumors in models of breast cancer
25. Use of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: Inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L
26. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast
27. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
28. Antiviral activity of flavones and potentiation by ascorbate
29. Prooxidant character of flavonoid cytotoxicity: Structure-activity relationships
30. Genistein exerts multiple suppressive effects similarly in estrogen receptor-positive and -negative human breast carcinoma cell lines characterized by P21/WAF1/CIP1 induction, G2/M arrest, and apoptosis
31. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro
32. Prolactin synthesis by cultured rat pituitary cells: An assay to study estrogens, antiestrogens and their metabolites in vitro
33. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells
34. Estrogenic flavonoids: Structural requirements for biological activity
35. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
36. Dietary estrogens - A probable cause of infertility and liver disease in captive cheetahs
37. Dietary estrogens - A biologically active background for estrogen action
38. The phytoestrogens present in de-ethanolized bourbon are biologically active: A preliminary study in postmenopausal women
39. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other uterovaginotrophic compounds of low potency
40. 3H]oestradiol by uterus, vagina and skeletal muscle of immature mice
41. Inhibition of human estrogen synthetase (aromatase) by flavones
42. Aromatase inhibition by flavonoids
43. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens
44. Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids
45. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study
46. Effects of pinostrobin on estrogen metabolism and estrogen receptor transactivation
47. Effects of phytoestrogens on aromatase, 3β- and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells
48. Genistein, a specific inhibitor of tyrosine-specific protein kinases
49. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II
50. Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones
51. The nuclear matrix from rat liver is capable of phosphorylating exogenous tyrosine-containing substrates
52. Effects of matrix components on aromatase activity in breast stromal cells in culture
53. Androgens influence estrogen-induced responses in hormone responsive human breast carcinoma cells through cytochrome P450 aromatase
54. Synthesis, structure elucidation, and biochemical evaluation of 7α- and 7β-arylaliphatic substituted androst-4-ene-3,17-diones as inhibitors of aromatase
55. Classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
56. Novel synthetic routes suitable for constructing benzopyrone combinatorial libraries
57. A novel synthesis of 2,3-disubstituted benzopyran-4-ones and application to the solid phase
58. A convenient method for synthesizing 2-aryl-3-hydroxy-4-oxo-4H-1-benzopyrans or flavonoids
59. Regiospecific carbonylative annulation of iodophenol acetates and acetylenes to construct the flavones by a new catalyst of palladium-thiourea-dppp complex